| Kingman Regional Medical Center Home Health | |
| 2202 Stockton Hill Road, Suite 200, Kingman, Arizona 86401 | |
| (928) 757-0630 | |
| Name | Kingman Regional Medical Center Home Health |
|---|---|
| Location | 2202 Stockton Hill Road, Suite 200, Kingman, Arizona |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 37050 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 86401, 86409, 86413, 86431, 86441, 86444 |
| NPI Number | 1174701478 |
| Organization Name | KINGMAN HEALTHCARE, INC |
| Doing Business As | KINGMAN HOSPITAL, INC |
| Address | 2202 N Stockton Hill Rd Ste 200, Kingman, AZ 86401 |
| Phone Number | 928-757-0630 |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
| NPI Number | 1265423917 |
| Organization Name | KINGMAN HEALTHCARE, INC |
| Doing Business As | KINGMAN HOSPITAL, INC |
| Address | 3269 N Stockton Hill Rd, Kingman, AZ 86409 |
| Phone Number | 928-681-8655 |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
| Quality Rating: |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 96.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
| How often the home health team checked patients for depression | 99.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 65.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 79.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.3 | 96.4 |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 75.3 | 79.6 |
| How often patients got better at getting in and out of bed | 77.7 | 81.1 |
| How often patients got better at bathing | 82.9 | 82.3 |
| How often patients’ breathing improved | 73.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 100 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 75.5 | 75 |
| How often home health patients had to be admitted to the hospital | 8.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 19.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 97.4 | 94 |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
The patient survey data of Kingman Regional Medical Center Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
ConjuChem Biotechnologies today announced financial results for the second quarter of fiscal 2010, ended April 30, 2010.
Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
› Verified 6 days ago
Kingman Regional Medical Center Home Health Location: 2202 Stockton Hill Road, Suite 200, Kingman, Arizona 86401 Ratings: Phone: (928) 757-0630 | |
Hualapai Home Health Care, Inc Location: 2505 Hualapai Mountain Road, Suite E, Kingman, Arizona 86401 Ratings: Phone: (928) 753-9015 | |
Premier Home Health Agency, Llc Location: 3555 Western Avenue, Kingman, Arizona 86409 Ratings: Phone: (928) 377-1004 |